Health ASCO 2023: IDH mutation and improved cognitive functions in brain tumor patients by Alexandra Hartman Editor-in-Chief June 4, 2023 written by Alexandra Hartman Editor-in-Chief June 4, 2023 53 2023-06-04 12:19:42 – ASCO 2023 ASCO 2023 Patients with this tumor with the IDH 1 and 2 mutation improve their motor and cognitive functions, in addition to avoiding long-term relapses. Grade 2 gliomas with a mutation in the IDH gene are malignant brain tumors that cause considerable morbidity and premature death. 1685882522 #Vorasidenib #stops #grade #glioma #surgery #delays #chemo #radium Share this: Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X 0 comments 0 FacebookTwitterPinterestEmail Alexandra Hartman Editor-in-Chief Editor-in-Chief Prize-winning journalist with over 20 years of international news experience. Alexandra leads the editorial team, ensuring every story meets the highest standards of accuracy and journalistic integrity. previous post Despite Dementia, Bruce Willis Enjoys a Day at Disneyland with Wife and Children next post Amazon is negotiating with US carriers to provide low-cost mobile phone service You may also like Jacksonville Veterans: Improved Access to VA & Military... February 23, 2026 Pecans & Heart Health: 5 Lifestyle Changes to... February 23, 2026 GP Partnership Model: Support High, Take-Up Low –... February 23, 2026 Medication & Pill Organizers: Risks & How to... February 23, 2026 Tipperary Dentist Jailed for €58,000 HSE Fraud |... February 23, 2026 Brain Metastases: New Therapies & Improved Quality of... February 23, 2026 Berkeley Schools Report Rare Mumps Cases | Bay... February 23, 2026 Y Chromosome Variation, Mosaic Loss, and Disease Risk... February 23, 2026 Cheese Recall: Aldi, Kaufland & Netto – Listeria... February 23, 2026 TikTok Star Pookie Puckett Announces Pregnancy February 23, 2026 Leave a Comment Cancel Reply Δ This site uses Akismet to reduce spam. Learn how your comment data is processed.
